MaxCyte, Inc.MXCTNASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank31
3Y CAGR-23.9%
5Y CAGR-51.4%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
-23.9%/yr
vs -58.1%/yr prior
5Y CAGR
-51.4%/yr
Recent acceleration
Acceleration
+34.1pp
Accelerating
Percentile
P31
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineCompressed
PeriodValueYoY Change
20250.96-54.5%
20242.11+1.2%
20232.09-4.4%
20222.19-37.8%
20213.51-90.1%
202035.54-49.6%
201970.49-0.5%
201870.85+67.9%
201742.20-62.4%
2016112.08-